Silence Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	5.66	11.28	121.33	68.79	66.05	99.57
Short-Term Investments	64.42	73.84	26	-	19.67	-
Cash & Short-Term Investments	70.08	85.11	147.33	68.79	85.72	99.57
Cash Growth	-48.67%	-42.23%	114.18%	-19.75%	-13.91%	94.75%
Accounts Receivable	-	-	0.97	0.29	1.1	0.45
Other Receivables	22.22	24.61	25.94	23.69	19.79	11.04
Receivables	22.22	24.61	26.91	23.98	20.9	11.49
Prepaid Expenses	-	8.93	13.12	10.39	9.88	5.83
Other Current Assets	10.56	-	-	-	-	-
Total Current Assets	102.85	118.66	187.37	103.15	116.5	116.9
Property, Plant & Equipment	1.54	1.75	1.98	2.31	2.65	2.63
Long-Term Investments	-	-	-	-	0.34	0.41
Goodwill	10.36	10.62	9.39	9.98	9.65	10.28
Other Intangible Assets	0.25	0.29	0.31	0.36	0.39	0.03
Other Long-Term Assets	0.13	0.13	3.59	3.65	-	-
Total Assets	115.12	131.44	202.64	119.45	129.53	130.25
Accounts Payable	10.37	4.41	3.7	3.35	3.84	5.5
Accrued Expenses	-	8.91	12.05	11.72	10.67	8.85
Current Portion of Leases	0.09	0.09	0.12	0.23	0.54	0.19
Current Income Taxes Payable	-	0.04	0.65	0.47	0.71	0.25
Current Unearned Revenue	-	0.17	0.31	6.57	10.68	5.75
Total Current Liabilities	10.46	13.61	16.82	22.34	26.44	20.54
Long-Term Leases	0.04	0.07	-	0.12	-	-
Long-Term Unearned Revenue	55.22	55.45	51.79	75	76.49	98.17
Total Liabilities	65.72	69.14	68.61	97.46	102.93	118.71
Common Stock	10.29	10.29	10.29	8.85	6.49	6.08
Additional Paid-In Capital	620.01	617.56	609.56	455.77	273.11	249.6
Retained Earnings	-577.53	-562.57	-474.04	-431.89	-317.2	-301.91
Comprehensive Income & Other	-3.37	-2.98	-11.78	-10.73	64.19	57.78
Shareholders' Equity	49.4	62.3	134.02	21.99	26.59	11.54
Total Liabilities & Equity	115.12	131.44	202.64	119.45	129.53	130.25
Total Debt	0.14	0.16	0.12	0.35	0.54	0.19
Net Cash (Debt)	69.94	84.95	147.22	68.44	85.18	99.39
Net Cash Growth	-48.75%	-42.29%	115.09%	-19.65%	-14.29%	96.17%
Net Cash Per Share	1.48	1.80	3.18	1.85	2.65	3.35
Filing Date Shares Outstanding	47.23	47.23	47.22	46.5	35.95	29.93
Total Common Shares Outstanding	47.23	47.23	47.22	39.62	35.94	29.93
Working Capital	92.39	105.05	170.54	80.82	90.06	96.36
Book Value Per Share	1.05	1.32	2.84	0.56	0.74	0.39
Tangible Book Value	38.8	51.4	124.32	11.65	16.56	1.23
Tangible Book Value Per Share	0.82	1.09	2.63	0.29	0.46	0.04
Machinery	-	5.54	6.34	6.44	6.01	6.92

Source: S&P Global Market Intelligence. Standard template. Financial Sources.